2027 Keystone Symposia on Healthy Aging & Therapeutic Opportunities
· Taipei
Building pharmaceutical superintelligence — from target discovery to the clinic.
Founder of a clinical-stage biotech that brought the first end-to-end generative-AI–designed drug into Phase II trials. Pioneer in AI for drug discovery and longevity research since 2014.
Main channels: Forever.ai and LinkedIn · Contributor to Fortune and Fast Company
· Taipei
· Washington, DC
· Hong Kong
· Abu Dhabi
· New York
· Virtual
· Paris
· Paris
· New York
· Las Vegas
· Copenhagen
· Split, Croatia
· Hong Kong
· London
· London
· San Diego
· Shanghai
· Copenhagen
· London
· Redmond Seattle
· Riyadh
· Park City
· Hong Kong
· Shanghai
· New York
· Shanghai
· Virtual
· Boston
· Singapore
· Singapore
"I pledge to dedicate 100% of my professional time and effort to the cause of extending healthy human lifespan through science, technology, and ethical advocacy."
Founded by Alex Zhavoronkov — a public commitment to devote one's career to longevity research and healthspan extension.